Research hints at detecting autism risk in pregnant mothers

Image
ANI Washington D.C. [USA]
Last Updated : Sep 22 2018 | 7:20 AM IST

A recent study indicates that if a woman has previously had a child with autism spectrum disorder (ASD), the risk of having a second child with ASD is more than in the general.

In a number of recent studies, researchers at Rensselaer Polytechnic Institute made enormous strides toward ASD prediction and diagnosis.

Estimates indicated that if a mother has previously had a child with ASD, the risk of having a second child with ASD is approximately 18.7 per cent, whereas the risk of ASD in the general population is approximately 1.7 per cent.

"However," said Hahn, a researcher, "it would be highly desirable if a prediction based upon physiological measurements could be made to determine which risk group a prospective mother falls into."

Researchers worked in developing a physiological test to predict autism risk, which has a larger emphasis on Alzheimer's and neurodegenerative diseases.

In this study, metabolites of the folate-dependent transmethylation and transsulfuration biochemical pathways of pregnant women were measured to determine whether or not the risk of having a child with autism could be predicted by her metabolic profile.

Pregnant mothers who have had a child with autism before were separated into two groups based on the diagnosis of their child whether the child had autism or not. Then these mothers were compared to a group of control mothers who have not had a child with autism before.

The researchers concluded that while it is not possible to determine during a pregnancy if a child will be diagnosed with ASD by age 3, they did find that differences in the plasma metabolites are indicative of the relative risk (18.7 per cent vs 1.7 per cent) for having a child with ASD.

"These are exciting results as they hint at differences in some metabolic processes that potentially play a role in increasing the risk of having a child with ASD," said Hahn.

This new research followed an earlier study, which developed an algorithm based on levels of metabolites found in a blood sample that can accurately predict whether a child is on the autism spectrum. A follow-up study this spring was also highly promising in assessing whether a child is on the autism spectrum.

The findings appeared in the Journal of Research in Autism Spectrum Disorders.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 22 2018 | 7:20 AM IST

Next Story